TNRC18 and acute myeloid leukemia: Interestingly, all four cases carrying XPO1-TNRC18 belonged to the M7 group and did not harbor any known AML-driving fusion, supporting that this fusion was the potential driver of AML in these cases, and might define a previously unclassified molecular subtype within this FAB group.